Menu
GeneBe

HARS2

histidyl-tRNA synthetase 2, mitochondrial, the group of Aminoacyl tRNA synthetases, Class II

Basic information

Region (hg38): 5:140691429-140699305

Previous symbols: [ "HARSL" ]

Links

ENSG00000112855NCBI:23438OMIM:600783HGNC:4817Uniprot:P49590AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Perrault syndrome 2 (Strong), mode of inheritance: AR
  • Perrault syndrome (Supportive), mode of inheritance: AR
  • Perrault syndrome 2 (Limited), mode of inheritance: AR
  • Perrault syndrome 2 (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Perrault syndrome 2ARAudiologic/OtolaryngologicEarly recognition and treatment of hearing impairment may improve outcomes, including speech and language developmentAudiologic/Otolaryngologic; Endocrine; Genitourinary; Obstetric517579; 21464306
Females have been described as being affected by genitourinary anomalies in addition to hearing impairment

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the HARS2 gene.

  • not provided (129 variants)
  • not specified (30 variants)
  • Inborn genetic diseases (22 variants)
  • Perrault syndrome 2 (13 variants)
  • Perrault syndrome (2 variants)
  • Sensorineural hearing loss disorder (2 variants)
  • HARS2-related condition (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the HARS2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
26
clinvar
1
clinvar
28
missense
1
clinvar
4
clinvar
65
clinvar
4
clinvar
74
nonsense
1
clinvar
2
clinvar
2
clinvar
5
start loss
0
frameshift
2
clinvar
1
clinvar
3
inframe indel
2
clinvar
2
splice donor/acceptor (+/-2bp)
0
splice region
4
7
11
non coding
1
clinvar
3
clinvar
22
clinvar
10
clinvar
36
Total 5 6 74 52 11

Highest pathogenic variant AF is 0.0000657

Variants in HARS2

This is a list of pathogenic ClinVar variants found in the HARS2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
5-140691617-C-T not specified Likely benign (Nov 10, 2016)390694
5-140691645-C-G not specified Uncertain significance (Jun 08, 2015)228737
5-140691647-C-T not specified Uncertain significance (May 09, 2017)517388
5-140691655-C-G not specified Conflicting classifications of pathogenicity (Jan 09, 2024)137536
5-140691714-GC-G Pathogenic (Oct 05, 2023)2067878
5-140691720-C-A Sensorineural hearing loss disorder Likely pathogenic (Jan 17, 2019)635273
5-140691721-GCTTCGTGCACCGGGGCGGTCCGTTGCC-G Uncertain significance (Sep 15, 2022)2153560
5-140691724-T-G Inborn genetic diseases Uncertain significance (Sep 26, 2022)2313492
5-140691726-G-A Likely benign (Feb 05, 2022)2093623
5-140691742-C-G Uncertain significance (Jul 23, 2022)2136282
5-140691743-G-T Uncertain significance (Jan 08, 2024)2782844
5-140691748-C-A Inborn genetic diseases Uncertain significance (May 05, 2023)2544290
5-140693295-G-T Likely benign (Jul 17, 2018)1187517
5-140693331-CA-C Benign (Aug 06, 2019)1221130
5-140693331-C-CA Likely benign (Aug 10, 2019)1215658
5-140693478-TC-T HARS2-related disorder Likely benign (Oct 28, 2020)3048804
5-140693499-G-A HARS2-related disorder Likely benign (Aug 16, 2019)3053102
5-140693596-A-G HARS2-related disorder Likely benign (Dec 11, 2020)3031260
5-140693606-T-C Likely benign (Oct 03, 2023)2793214
5-140693607-T-G Conflicting classifications of pathogenicity (Mar 01, 2024)1176814
5-140693619-T-A Perrault syndrome 2 Likely pathogenic (May 20, 2019)633638
5-140693627-C-T not specified Uncertain significance (Feb 23, 2016)228735
5-140693633-G-A not specified Likely benign (Jan 07, 2014)214538
5-140693634-A-G Inborn genetic diseases Uncertain significance (Oct 12, 2022)214536
5-140693645-TTTA-T not specified Uncertain significance (Mar 08, 2022)228736

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
HARS2protein_codingprotein_codingENST00000230771 137879
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.00002790.9971256610871257480.000346
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.04392652670.9920.00001523296
Missense in Polyphen7482.8170.89354943
Synonymous-0.39010398.11.050.000004551000
Loss of Function2.601226.40.4540.00000142327

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0003370.000337
Ashkenazi Jewish0.000.00
East Asian0.001470.00147
Finnish0.000.00
European (Non-Finnish)0.0003520.000352
Middle Eastern0.001470.00147
South Asian0.0004250.000425
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Pathway
Aminoacyl-tRNA biosynthesis - Homo sapiens (human);Histidine Metabolism;Histidinemia;tRNA Aminoacylation;Translation;Metabolism of proteins;tRNA charging;Histidine metabolism;Mitochondrial tRNA aminoacylation;Histidine degradation (Consensus)

Recessive Scores

pRec
0.146

Intolerance Scores

loftool
0.633
rvis_EVS
-0.4
rvis_percentile_EVS
26.53

Haploinsufficiency Scores

pHI
hipred
N
hipred_score
0.283
ghis
0.599

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.997

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Hars2
Phenotype

Zebrafish Information Network

Gene name
hars
Affected structure
cranial blood vessel
Phenotype tag
abnormal
Phenotype quality
increased branchiness

Gene ontology

Biological process
translation;tRNA aminoacylation for protein translation;histidyl-tRNA aminoacylation
Cellular component
cytoplasm;mitochondrion;mitochondrial matrix;cytosol
Molecular function
RNA binding;histidine-tRNA ligase activity;protein binding;ATP binding;identical protein binding;protein homodimerization activity